Protein Therapeutics Market Size, Trends, Latest Insights and Industry Statistics 2023-2028

According to IMARC Group’s latest report, titled “Protein Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, the global protein therapeutics market size reached US$ 322.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 487.0 Billion by 2028, exhibiting a growth rate (CAGR) of 7% during 2023-2028.

Protein therapeutics refers to the use of proteins in medical treatments to modify or influence biological processes. These proteins, which may be naturally occurring or engineered, function as enzymes, antibodies, or hormones to treat a range of conditions, from cancer and autoimmune disorders to hormonal imbalances and metabolic diseases. Compared to traditional small-molecule drugs, protein therapeutics often offer higher specificity and efficacy with fewer side effects. This class of drugs is usually administered through injections, though research is ongoing to develop more convenient delivery methods.

Request a Free PDF Sample of the Report: 
https://www.imarcgroup.com/protein-therapeutics-market/requestsample

Protein Therapeutics Market Trends:

Progress in biotechnology, protein engineering, and genomics represents one of the key factors driving the growth of the market across the globe. This is facilitating the development of more effective and targeted protein therapeutics, which is driving the market growth. The rising incidence of chronic diseases like cancer, diabetes, and autoimmune disorders is creating a demand for more specific and efficient treatments, which is paving the way for protein therapeutics. Protein therapeutics allow for more personalized treatment plans, which are increasingly being favored over one-size-fits-all approaches, which is driving their demand. Increased investments in research and development (R&D) by pharmaceutical companies and public institutions are rushing the drug discovery process, which is fostering the market growth.

The growing availability and accessibility of protein therapeutics, especially in emerging markets, are contributing to the market's expansion. The growing awareness among patients about the advantages of protein therapeutics, such as reduced side effects and higher efficacy, is driving the demand for protein therapeutics. Strategic collaborations between biotech companies and pharmaceutical giants for research, development, and commercialization are fueling growth in this sector.


Key Market Segmentation:

The report has segmented the global protein therapeutics market based on product, therapy area, function and region.

Breakup by Product:

  • Monoclonal Antibodies (mAbs)
  • Human Insulin
  • Erythropoietin
  • Clotting Factors
  • Fusion Protein
  • Others

Breakup by Therapy Area:

  • Metabolic Disorders
  • Immunological Disorders
  • Hematological Disorders
  • Cancer
  • Hormonal Disorders
  • Genetic Disorders
  • Others

Breakup by Function:

  • Enzymatic and Regulatory Activity
  • Special Targeting Activity
  • Vaccines
  • Protein Diagnostics

Breakup by Region:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Competitive Landscape With Key Players:

The competitive landscape of the protein therapeutics market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

  • Amgen Inc.
  • Abbott Laboratories
  • Abbvie Inc.
  • Baxter International Inc.
  • Biogen Inc.
  • Csl Behring L.L.C. (CSL Limited)
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG (Roche Holding AG)
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novo Nordisk A/S (Novo Holdings A/S)
  • Pfizer Inc.

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2431&flag=C

Key Highlights of the Report:

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Media Contact:
Company Name:
 IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com/

Popular posts from this blog

GCC LED Lighting Market Size, Trends, Growth, Forecast & Industry Report 2024-2032

Europe Beer Market Share, Size, Forecast & Analysis 2023-2028

Bulletproof Glass Manufacturing Plant Project Report 2024: Industry Trends, Unit Setup and Machinery